Literature DB >> 24460713

Synergistic antitumor cytotoxic actions of ascorbate and menadione on human prostate (DU145) cancer cells in vitro: nucleus and other injuries preceding cell death by autoschizis.

Jacques Gilloteaux1, James M Jamison, Deborah Neal, Jack L Summers.   

Abstract

Scanning (SEM) and transmission electron microscopy (TEM) were used to characterize the cytotoxic effects of ascorbate (VC), menadione (VK3), or a VC:VK3 combination on a human prostate carcinoma cell line (DU145) following a 1-h vitamin treatment and a subsequent 24-h incubation in culture medium. Cell alterations examined by light and electron microscopy were treatment-dependent with VC + VK3 >VK3 > VC > Sham. Oxidative stress-induced damage was found in most organelles. This report describes injuries in the tumor cell nucleus (chromatin and nucleolus), mitochondria, endomembranes, lysosomal bodies (autophagocytoses) and inclusions. Morphologic alterations suggest that cytoskeleton damage is likely responsible for the superficial cytoplasmic changes, including major changes in cell shape and size and the self-excising phenomena. Unlike apoptotic bodies, the excised pieces contain ribonucleoproteins, but not organelles. These deleterious events cause a progressive, significant reduction in the tumor cell size. During nuclear alterations, the nuclei maintain their envelope during chromatolysis and karyolysis until cell death, while nucleoli undergo a characteristic segregation of their components. In addition, changes in fat and glycogen storage are consistent the cytotoxic and metabolic alterations caused by the respective treatments. All cellular ultrastructural changes are consistent with cell death by autoschizis and not apoptosis or other kinds of cell death.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24460713     DOI: 10.3109/01913123.2013.852645

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  8 in total

1.  Menadione induces G2/M arrest in gastric cancer cells by down-regulation of CDC25C and proteasome mediated degradation of CDK1 and cyclin B1.

Authors:  Min Ho Lee; Yoonjung Cho; Do Hyun Kim; Hyun Jun Woo; Ji Yeong Yang; Hye Jin Kwon; Min Ji Yeon; Min Park; Sa-Hyun Kim; Cheol Moon; Nagendran Tharmalingam; Tae Ue Kim; Jong-Bae Kim
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

2.  The Electroporation as a Tool for Studying the Role of Plasma Membrane in the Mechanism of Cytotoxicity of Bisphosphonates and Menadione.

Authors:  Mantas Šilkūnas; Rita Saulė; Danutė Batiuškaitė; Gintautas Saulis
Journal:  J Membr Biol       Date:  2016-04-04       Impact factor: 1.843

Review 3.  Menadione: a platform and a target to valuable compounds synthesis.

Authors:  Acácio S de Souza; Ruan Carlos B Ribeiro; Dora C S Costa; Fernanda P Pauli; David R Pinho; Matheus G de Moraes; Fernando de C da Silva; Luana da S M Forezi; Vitor F Ferreira
Journal:  Beilstein J Org Chem       Date:  2022-04-11       Impact factor: 2.544

Review 4.  Vitamin K and its analogs: Potential avenues for prostate cancer management.

Authors:  Subramanyam Dasari; Syed M Ali; Guoxing Zheng; Aoshuang Chen; Venkata Satish Dontaraju; Maarten C Bosland; Andre Kajdacsy-Balla; Gnanasekar Munirathinam
Journal:  Oncotarget       Date:  2017-05-19

5.  Selective Targeting of Cancerous Mitochondria and Suppression of Tumor Growth Using Redox-Active Treatment Adjuvant.

Authors:  Rumiana Bakalova; Severina Semkova; Donika Ivanova; Zhivko Zhelev; Thomas Miller; Tsuguhide Takeshima; Sayaka Shibata; Dessislava Lazarova; Ichio Aoki; Tatsuya Higashi
Journal:  Oxid Med Cell Longev       Date:  2020-11-02       Impact factor: 6.543

Review 6.  High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer.

Authors:  Franziska Böttger; Andrea Vallés-Martí; Loraine Cahn; Connie R Jimenez
Journal:  J Exp Clin Cancer Res       Date:  2021-10-30

7.  PEGylated Chitosan Nanoparticles Encapsulating Ascorbic Acid and Oxaliplatin Exhibit Dramatic Apoptotic Effects against Breast Cancer Cells.

Authors:  Sherif Ashraf Fahmy; Asmaa Ramzy; Asmaa A Mandour; Soad Nasr; Anwar Abdelnaser; Udo Bakowsky; Hassan Mohamed El-Said Azzazy
Journal:  Pharmaceutics       Date:  2022-02-13       Impact factor: 6.321

8.  Ascorbic Acid Chemosensitizes Colorectal Cancer Cells and Synergistically Inhibits Tumor Growth.

Authors:  Ana S Pires; Cláudia R Marques; João C Encarnação; Ana M Abrantes; Inês A Marques; Mafalda Laranjo; Rui Oliveira; João E Casalta-Lopes; Ana C Gonçalves; Ana B Sarmento-Ribeiro; Maria F Botelho
Journal:  Front Physiol       Date:  2018-07-23       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.